TupeloLife Digital Therapeutics to Present RPM Hypertension Control Program at Scientific Sessions
The Remote Patient Monitoring Company will Present Strategies to Achieve Positive Blood Pressure Outcomes for Patient with Chronic Conditions at the American Heart Association's Annual Conference
By: TupeloLife Digital Therapeutics
DALLAS - Nov. 8, 2021 - PRLog -- TupeloLife Digital Therapeutics (DTx) is set to participate in the American Heart Association's Scientific Sessions Annual Conference. The Dallas-based Remote Patient Monitoring (RPM) software and monitoring company will be participating in an expert panel session discussing blood pressure technology platforms and presenting in the Innovation Showcase. This year Scientific Sessions will be a virtual event taking place November 13 through the 15th.
TupeloLife's first session will take place on Saturday and will be a panelist discussion on Self-Measured Blood Pressure Platforms and Devices. This panel will include a description of the technology platforms that are used to support self-measured blood pressure (SMBP), especially in under-resourced communities. On Sunday, TupeloLife will present their company research and finding of their Value Based RPM program in the Innovation Showcase.
"We are excited to present our RPM Hypertension Control Program outcomes," said Rob Sanchez, Chief Operating Officer at TupeloLife DTx. "Using the Association's CarePlans along with our nurse led RPM program has led to positive control and drop in systolic readings. We've designed a simple and personable program to help our patients better manage and understand the importance of controlling their blood pressures."
Scientific Sessions 2021 offers the global educational experience to improve cardiovascular health, champion scientific discovery, and innovate clinical practice. The three-day event will feature talks, panels, symposiums, and virtual exhibitions.
About TupeloLife Digital Therapeutics
TupeloLife Digital Therapeutics is working at the convergence of technology and science to lower healthcare costs, improve healthcare access, and advance health outcomes for populations with chronic conditions. TupeloLife delivers remote patient monitoring software and services to health systems, health centers, physician practices, and employer wellness programs using the Precision Care Platform which provides clinicians secure access to patient data to monitor and intervene appropriately. The Platform also includes the Association's CarePlans with the aim of engaging patients to better manage their hypertension through behavior change.
TupeloLife is an Innovator's Network Member of the American Heart Association Center for Health Technology & Innovation.
For more information, please visit tupelolife.com (https://www.tupelolife.com/).
Contact
Michelle Melvin
***@tupelolife.com
